Literature DB >> 10567684

Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides.

T Hosoya1, H Takeuchi, Y Kanesaka, H Yamakawa, N Miyano-Kurosaki, K Takai, N Yamamoto, H Takaku.   

Abstract

The inhibition of specific transcription regulatory proteins is a new approach to control gene expression. The transcriptional activities of DNA-binding proteins can be inhibited by the use of double-stranded oligonucleotides that compete for the binding to their specific target sequences in promoters and enhancers. We used nicked (NDODN-kappaB) and circular (CDODN-kappaB) dumbbell DNA oligonucleotides containing a NF-kappaB binding site to analyze the inhibition of the NF-kappaB-dependent activation of the human immunodeficiency virus type-1 (HIV-1) enhancer. The dumbbell DNA oligonucleotides are stable, short segments of double-stranded DNA with closed nucleotide loops on each end, which confer resistance to exonucleases. The dumbbell and other oligonucleotides (decoys) with the NF-kappaB sequence were found to compete with the native strand for NF-kappaB binding. The circular dumbbell and double-stranded phosphorothioate oligonucleotides competed with the native strand for binding to the NF-kappaB binding proteins, while the nicked NF-kappaB dumbbell was a less effective competitor. In Jurkat T-cells, the dumbbell and other oligonucleotides were tested for their ability to block the activation of the plasmid HIV-NL4-3 Luc. The CDODN-kappaB strongly inhibits the specific transcriptional regulatory proteins, as compared with the NDODN-kappaB and the double stranded phosphodiester oligonucleotides. On the other hand, the double stranded phosphorothioate oligonucleotides could also block this activation, but the effect was non-specific. The circular (CDODN) dumbbell oligonucleotides may efficiently compete for the binding of specific transcription factors within cells, thus providing anti-HIV-1 or other therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567684     DOI: 10.1016/s0014-5793(99)01450-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Pseudorotaxane formation via the slippage process with chemically cyclized oligonucleotides.

Authors:  Kazumitsu Onizuka; Tomoko Chikuni; Takuya Amemiya; Takuya Miyashita; Kyoko Onizuka; Hiroshi Abe; Fumi Nagatsugi
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

3.  Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.

Authors:  Evan R Guggenheim; Dong Xu; Christiana X Zhang; Pamela V Chang; Stephen J Lippard
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

4.  Photochemical control of DNA decoy function enables precise regulation of nuclear factor κB activity.

Authors:  Jeane M Govan; Mark O Lively; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2011-07-29       Impact factor: 15.419

Review 5.  Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.

Authors:  Naruya Tomita; Naoki Kashihara; Ryuichi Morishita
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

6.  Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.

Authors:  Rita Crinelli; Marzia Bianchi; Lucia Gentilini; Linda Palma; Mads D Sørensen; Torsten Bryld; Ravindra B Babu; Khalil Arar; Jesper Wengel; Mauro Magnani
Journal:  Nucleic Acids Res       Date:  2004-03-29       Impact factor: 16.971

7.  Evaluation of different conditions for ligating dumbbell-shaped oligonucleotides.

Authors:  Hiroshi Yamagiwa; Mark E Bolander; Gobinda Sarkar
Journal:  Mol Biotechnol       Date:  2004-02       Impact factor: 2.695

8.  Radiolytic reduction characteristics of artificial oligodeoxynucleotides possessing 2-oxoalkyl group or disulfide bonds.

Authors:  Kazuhito Tanabe; Takeo Ito; Sei-Ichi Nishimoto
Journal:  J Nucleic Acids       Date:  2011-08-08

9.  Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo.

Authors:  Yasuo Kunugiza; Tetsuya Tomita; Naruya Tomita; Ryuichi Morishita; Hideki Yoshikawa
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD.

Authors:  Christian Klingler; Jon Ashley; Ke Shi; Adeline Stiefvater; Michael Kyba; Michael Sinnreich; Hideki Aihara; Jochen Kinter
Journal:  FASEB J       Date:  2020-02-05       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.